Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.

Morel J, Dernis E, Roux C, Richez C, Brocq O, Fautrel B, Salliot C, Vittecoq O, Mariette X, Lioté F, Lassoued S, Gaujoux-Viala C, Constantin A, Soubrier M, Devauchelle-Pensec V, Goeb V, Gottenberg JE, Marotte H, Moulard AR, Daien C, Mouterde G, Lukas C, Pissarra J, Huguet H, Launay O, Galtier F, Picot MC, I-REIVAC, CRI-IMIDIATE French Clinical Research Networks

Open source

DOI
10.1016/s2665-9913(25)00071-2
Published
2025 Oct
Container
The Lancet. Rheumatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2665-9913-25-00071-2,
  title = {Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.},
  author = {Morel J and Dernis E and Roux C and Richez C and Brocq O and Fautrel B and Salliot C and Vittecoq O and Mariette X and Lioté F and Lassoued S and Gaujoux-Viala C and Constantin A and Soubrier M and Devauchelle-Pensec V and Goeb V and Gottenberg JE and Marotte H and Moulard AR and Daien C and Mouterde G and Lukas C and Pissarra J and Huguet H and Launay O and Galtier F and Picot MC and I-REIVAC and CRI-IMIDIATE French Clinical Research Networks},
  year = {2025},
  journal = {The Lancet. Rheumatology},
  doi = {10.1016/s2665-9913(25)00071-2},
  url = {https://doi.org/10.1016/s2665-9913(25)00071-2}
}

RIS

TY  - JOUR
TI  - Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.
AU  - Morel J
AU  - Dernis E
AU  - Roux C
AU  - Richez C
AU  - Brocq O
AU  - Fautrel B
AU  - Salliot C
AU  - Vittecoq O
AU  - Mariette X
AU  - Lioté F
AU  - Lassoued S
AU  - Gaujoux-Viala C
AU  - Constantin A
AU  - Soubrier M
AU  - Devauchelle-Pensec V
AU  - Goeb V
AU  - Gottenberg JE
AU  - Marotte H
AU  - Moulard AR
AU  - Daien C
AU  - Mouterde G
AU  - Lukas C
AU  - Pissarra J
AU  - Huguet H
AU  - Launay O
AU  - Galtier F
AU  - Picot MC
AU  - I-REIVAC
AU  - CRI-IMIDIATE French Clinical Research Networks
PY  - 2025
JO  - The Lancet. Rheumatology
DO  - 10.1016/s2665-9913(25)00071-2
UR  - https://doi.org/10.1016/s2665-9913(25)00071-2
ER  - 

APA

J, M., E, D., C, R., C, R., O, B., B, F., C, S., O, V., X, M., F, L., S, L., C, G., A, C., M, S., V, D., V, G., JE, G., H, M., AR, M., C, D., G, M., C, L., J, P., H, H., O, L., F, G., MC, P., I-REIVAC, & Networks, C. F. C. R. (2025). Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(25)00071-2

Source records